Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01528748|
Recruitment Status : Active, not recruiting
First Posted : February 8, 2012
Last Update Posted : October 27, 2016
|Condition or disease||Intervention/treatment|
|Depressive Disorder Major Depressive Disorder Dysthymic Disorder Alcohol-Related Disorders Alcoholism||Behavioral: Cognitive Behavioral Analysis System of Psychotherapy|
|Study Type :||Observational|
|Actual Enrollment :||8 participants|
|Official Title:||Clinical Trial of CBASP for Individuals With Co-occurring Chronic Depression and Alcohol Dependence|
|Study Start Date :||April 2011|
|Actual Primary Completion Date :||December 2015|
|Estimated Study Completion Date :||July 2018|
Chronically Depressed, Alcohol Dependent
Participants who have been formally diagnosed with a clinical diagnosis of Chronic Depression and Alcohol Dependence.
Behavioral: Cognitive Behavioral Analysis System of Psychotherapy
Cognitive Behavioral Analysis System of Psychotherapy (CBASP) is a behavioral intervention that addresses the unique behavioral characteristics of chronically depressed individuals, most of which are highly relevant for alcoholics as well. CBASP has a structured, individualized, and collaborative (patient and clinician) design. The intervention emphasizes teaching effective coping strategies and employing motivational, cognitive, behavioral, and interpersonal techniques. Individual therapy (1 hour) sessions occur on a weekly basis for a total of 20 sessions over a period of 21 weeks.
Other Name: CBASP
- Depression Rating [ Time Frame: Baseline and 20 weeks ]Change in depression rating scale over time.
- Drinking behavior [ Time Frame: Baseline and 20 weeks ]Change in number of drinks consumed per day over time.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01528748
|United States, Virginia|
|University of Virginia Center for Addiction Research & Education (UVa CARE)|
|Charlottesville, Virginia, United States, 22911|
|Principal Investigator:||Jennifer K. Penberthy, Ph.D.||University of Virginia, School of Medicine, Department of Psychiatry & Neurobehavioral Sciences|